Search alternatives:
significant made » significant male (Expand Search), significant main (Expand Search), significant models (Expand Search)
non decrease » point decrease (Expand Search), note decreased (Expand Search), fold decrease (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), mean decrease (Expand Search)
made based » image based (Expand Search)
significant made » significant male (Expand Search), significant main (Expand Search), significant models (Expand Search)
non decrease » point decrease (Expand Search), note decreased (Expand Search), fold decrease (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), mean decrease (Expand Search)
made based » image based (Expand Search)
-
101
Annual treatment frequencies in recurrence and non-recurrence groups.
Published 2025“…<p>In the recurrence group, the respective treatment counts for anti-VEGF, STTA, MA-PC, PPV, and total treatments (mean ± standard deviation) in the year before surgery were 3.0 ± 1.4, 0.1 ± 0.3, 0.8 ± 1.0, 0.1 ± 0.3, and 4.0 ± 2.1, respectively. These significantly decreased to 2.3 ± 2.6, 0.1 ± 0.3, 0.8 ± 1.6, 0.0, and 3.1 ± 2.8 in the first year; 2.1 ± 2.8, 0.4 ± 1.0, 0, 0.1 ± 0.3, and 2.6 ± 2.8 in the second year; and 2.0 ± 2.2, 0, 0.6 ± 1.7, 0.1 ± 0.3, and 2.8 ± 3.5 in the third year (Kruskal–Wallis test, p < 0.001; Dunn’s test, *P < 0.05, **P < 0.01). …”
-
102
-
103
-
104
-
105
-
106
-
107
-
108
-
109
-
110
-
111
-
112
Significant clusters for zero-dose children aged 12-23 months in Ethiopia, 2023.
Published 2025Subjects: -
113
-
114
-
115
Demographic of the study participants, urinary arsenic species and Th17 cells.
Published 2022Subjects: -
116
-
117
-
118
Demographic of the study participants, urinary arsenic species and IL-17A cytokine.
Published 2022Subjects: -
119
-
120